References
- Warburg O, Wind F, Negalein E. The metabolism of tumours in the body. J Physiol 1927; 8: 519–30
- Nolop K B, Rhodes C G, Brudin L H, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987; 60: 2682–9
- Deshpande N, Mitchell I, Millis R. Enzyme studies in human breast tumours. Eur J Cancer 1977; 13: 1261–7
- Hennipman A, van Oirschol B A, Smits J, Rijksen G, Staal G EJ. Heterogeneity of Glyolytic enzyme activity and isozyme composition of pyruvate kinase in breast cancer. Tumor Biol 1988; 9: 178–89
- Tokunga K, Nakamura Y, Sakata K, et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987; 47: 5616–9
- Scheck N, Hall B L, Finn O J. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma. Cancer Res 1988; 48: 6354–9
- Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumour: a review. Cancer Res 1989; 49: 6449–65
- Brown J. Effects of 2-deoxyglucose on carbohydrate metabolism: Review of the literature and studies in the rat. Metabolism 1962; 11: 1098–112
- Cay O, Radnell M, Jeppson B, Ahren B, Bengmark S. Inhibitory effect of 2-deoxy-D-glucose on liver tumour growth in rats. Cancer Res 1992; 52: 5794–6
- Landau B R, Lazlo J, Stengle J, Burk D. Certain metabolic and pharmacologic effects in cancer patients given infusions of 2-deoxy-D-glucose. J Natl Cancer Inst 1958; 21: 485–94
- Novoa W B, Winer A D, Glaid A J, Schwert G W. Lactic dehydrogenase, V. Inhibition by oxamate and oxalate. J Biol Chem 1959; 234: 1143–8
- Goldberg E B, Colowick S P. The role of glycolysis in the growth of tumour cells, III. Lactic dehydrogenase as the site of action of oxamate on the growth of cultured cells. J Biol Chem 1965; 240: 2786–90
- Freyer J P, Sutherland R M. Selective dissociation and characterisation of cells from different regions of multicell tumour spheroids. Cancer Res 1980; 40: 3956–65
- Floridi A, Paggi M G, D'Atri S, et al. Effect of lonidamine on the energy metabolism of Ehrlich ascited tumours. Cancer Res 1981; 41: 4661–6
- Hahn G M, van Kersen I, Silvestrini B. Inhibition of recovery from potentially lethal damage by lonidamine. Br J Cancer 1984; 50: 657–60
- Teicher B A, Herman T S, Holden S A, Epelbaum R, Liu S, Frei E. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo. Cancer Res 1991; 51: 780–4
- Purohit S C, Pohlit W. Experimental evaluation of the glucose antimetabolite 2-DG as a possible adjuvant to radiotherapy of tumours. Int J Radiat Oncol Biol Phys. 1982; 8: 495–9